Scharf Investments, LLC Novartis Ag Transaction History
Scharf Investments, LLC
- $2.96 Billion
- Q4 2024
A detailed history of Scharf Investments, LLC transactions in Novartis Ag stock. As of the latest transaction made, Scharf Investments, LLC holds 1,203,323 shares of NVS stock, worth $135 Million. This represents 3.96% of its overall portfolio holdings.
Number of Shares
1,203,323
Previous 1,277,793
5.83%
Holding current value
$135 Million
Previous $147 Million
20.33%
% of portfolio
3.96%
Previous 4.52%
Shares
31 transactions
Others Institutions Holding NVS
# of Institutions
1,478Shares Held
134MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.37 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.24 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$918 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$770 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$625 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $241B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...